Chi Sheng Chemical Corp. Reports Earnings Results for the Full Year Ended December 31, 2018
March 18, 2019 at 10:42 am
Share
Chi Sheng Chemical Corp. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced total revenue was TWD 967.402 million compared to TWD 1,044.538 million a year ago. Operating income was TWD 42.636 million compared to TWD 103.324 million a year ago. Net income was TWD 42.250 million compared to TWD 81.739 million a year ago. Basic earnings per share was TWD 0.74 compared to TWD 1.43 a year ago.
Chi Sheng Pharma & Biotech Co., Ltd, formerly Chi Sheng Chemical Corporation is principally engaged in the manufacture and distribution of general medicines and medicinal injections. The Company provides injections, including hemodialysis concentrate, amino acid injection with electrolytes, vitamins, cephalosporin antibiotics, antihistamines and antipruritics, as well as ginkgo injections; oral preparations, including antibiotics, cold syrups and liquid antacid; external medicines, including contact lens fluid, normal saline for wash and povidone-iodine solution, and consumer goods, including functional health foods, skin care products and cosmetics. It also provides medical devices and equipment. The Company distributes its products in domestic markets and to overseas markets, including Mainland China and Southeast Asia.
CHI SHENG PHARMA & BIOTECH CO., LTD 
